Expression of cell cycle regulator cdk2ap1 suppresses tumor cell phenotype by non-cell-autonomous mechanisms
Olga Zolochevska1, Marxa L Figueiredo
1Department of Comparative Biomedical Sciences, Louisiana State University, Baton Rouge, 70803, United States.
Abstract:
We evaluated the effect of expressing the cell cycle regulator cdk2ap1 in epithelial or stromal cell compartments to reduce SCC growth in vitro and in vivo. Cell-autonomous and/or non-cell-autonomous expression of cdk2ap1 reduced tumor growth and invasion and altered cell cycle, adhesion, invasion, angiogenesis, and apoptotic gene expression, as assessed by several in vitro phenotype assays, quantitative real-time PCR, and in vivo molecular imaging using a novel three-way xenograft animal model. Our findings suggest that the interactions between cancer cells and fibroblasts that promote abnormal growth can be minimized by expressing cdk2ap1, supporting a novel concept by which tumor/growth suppressor genes can impact tumorigenesis phenotypes from non-cell-autonomous interactions within the tumor microenvironment.
Insights
Expressing cdk2ap1 in cancer cells or surrounding fibroblasts reduces squamous cell carcinoma (SCC) growth and invasion. This study highlights cdk2ap1
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Squamous cell carcinoma (SCC) growth is influenced by interactions between cancer cells and the tumor microenvironment.
- The cell cycle regulator cdk2ap1's role in SCC tumorigenesis is not fully understood.
Purpose of the Study:
- To investigate the effect of cdk2ap1 expression in epithelial and stromal cells on SCC growth.
- To elucidate the mechanisms by which cdk2ap1 influences tumor progression.
Main Methods:
- In vitro phenotype assays and quantitative real-time PCR were used to assess gene expression changes.
- In vivo studies utilized a novel three-way xenograft animal model for molecular imaging.
- cdk2ap1 was expressed in either epithelial or stromal cell compartments.
Main Results:
- Expression of cdk2ap1 in either cell type significantly reduced SCC tumor growth and invasion.
- cdk2ap1 altered the expression of genes involved in cell cycle, adhesion, invasion, angiogenesis, and apoptosis.
- Non-cell-autonomous effects of cdk2ap1 on tumor microenvironment interactions were observed.
Conclusions:
- cdk2ap1 acts as a tumor suppressor by modulating cell-autonomous and non-cell-autonomous pathways.
- Targeting cdk2ap1 interactions within the tumor microenvironment offers a novel therapeutic strategy for SCC.
- Minimizing cancer cell-fibroblast interactions through cdk2ap1 expression can inhibit SCC progression.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...


